| Literature DB >> 34616165 |
Basma Damiri1, Omar Khatib2, Zaher Nazzal3, Diala Sanduka2, Siwar Igbaria2, Ammar Thabaleh2, Ahmad Farhoud2, Lubna Saudi3, Souad Belkebir3, Rayyan Al Ali4, Mohammed Alili2, Mahmoud Hamdan5, Omar A Safarini2, Omar Younis2.
Abstract
INTRODUCTION: Due to their stressful lives, Palestinian refugees are prone to use cognitive enhancers (CE) and psychostimulant substances (PS). Recognising health problems associated with CE/PS use can indicate how preventive programs should be directed towards adolescents. Unfortunately, research has not thoroughly investigated the health problems related to tobacco and caffeine products, the most socially acceptable CE/PS among Palestinian refugee adolescents.Entities:
Keywords: UNRWA; cognitive enhancers and psychostimulants; dyslipidemia; metabolic syndrome; refugee adolescents; tobacco smoking
Year: 2021 PMID: 34616165 PMCID: PMC8487859 DOI: 10.2147/DMSO.S329675
Source DB: PubMed Journal: Diabetes Metab Syndr Obes ISSN: 1178-7007 Impact factor: 3.168
The Prevalence, Pattern of Use, and Initiation Age of Tested CE/PS in Refugee Schoolchildren
| Gender | Tobacco and Caffeine Products | Practice# | Pattern of Use# | Initiation Age in Years | ||||
|---|---|---|---|---|---|---|---|---|
| Daily | Several Times Weekly | Several Times Monthly | Several Times Yearly | Ex-User | Median (Q1, Q3) or Mean (SD) | |||
| Males | Cigarettes | 31(18.2) | 15(38.5) | 8(20.5) | 5(12.8) | 3(7.7) | 8(20.5) | 10.2(1.8) |
| Waterpipe | 48(28.2) | 11(20.8) | 20(37.7) | 14(26.4) | 7(13.2) | 1(1.9) | 11.6(1.4) | |
| Energy drinks | 110(64.7) | 31(26.7) | 59(50.9) | 18(15.5) | 4(3.4) | 4(3.4) | 10.5(2.4) | |
| Coffee | 134(78.4) | 51(40.2) | 52(40.9) | 15(11.8) | 9(7.1) | 0(0.0) | 10 (7.5, 11) | |
| Black tea | 162(94.7) | 98(64.5) | 51(33.6) | 1(0.7) | 2(1.3) | 0(0.0) | 9(7, 9) | |
| Chocolate | 161(95.3) | 90(60.8) | 46(31.1) | 11(7.4) | 1(0.7) | 0(0.0) | 6 (6, 7) | |
| Females | Cigarettes | 4(2.5) | 0(0.0) | 1(16.7) | 1(16.7) | 3(50.0) | 1(16.7) | 11(9.5, 11.5) |
| Waterpipe | 11(6.9) | 3(12.5) | 4(16.7) | 4(16.7) | 8(33.3) | 5(20.8) | 12(11, 13) | |
| Energy drinks | 53(32.5) | 16(22.5) | 29(40.8) | 7(9.9) | 14(19.7) | 5(7.0) | 10.4(2.2) | |
| Coffee | 121(74.7) | 25(22.3) | 55(49.1) | 24(21.4) | 8(7.2) | 0(0.0) | 11 (10, 12) | |
| Black tea | 133(83.1) | 71(58.2) | 36(29.5) | 6(4.9) | 9(7.4) | 0(0.0) | 9(7, 10) | |
| Chocolate | 148(91.9) | 70(51.1) | 47(34.3) | 11(7.4) | 3(1.2) | 6(4.4) | 6(6, 7) | |
Note: #Data shown as n(%).
Abbreviation: CE/PS, cognitive enhancers/psychostimulants.
The Prevalence of MetS and Metabolic Abnormalities in Refugee Schoolchildren
| Total | Males | Females | P-value | ||
|---|---|---|---|---|---|
| MetS | Yes | 17(6.3) | 10(7.4) | 7(5.1) | 0.44 |
| WC (cm) | High | 18(5.4) | 16(9.4) | 2(1.2) | 0.001* |
| FBS (mg/dL) | High | 23(8.5) | 14(10.4) | 9(6.6) | 0.26 |
| HDL (mg/dL) | Low | 160(40.8) | 78(42.4) | 82(39.4) | 0.55 |
| Triglycerides (mg/dL) | High | 28(10.3) | 16(11.9) | 12(8.8) | 0.40 |
| Total cholesterol (mg/dL) | High | 11(4.0) | 5(3.7) | 6(4.4) | 0.78 |
| LDL (mg/dL) | High | 10(3.7) | 4(3.0) | 6(4.4) | 0.75 |
| DBP (mmHg) | High | 26(7.9) | 11(6.5) | 15(9.3) | 0.35 |
| SBP (mmHg) | High | 29(8.8) | 11(6.5) | 18(11.2) | 0.14 |
| BMI based on WHO (kg/m2) | Underweight | 14(4.2) | 9(5.3) | 5(3.1) | 0.69 |
| Normal weight | 164(49.1) | 80(46.8) | 84(51.5) | ||
| Overweight | 74(22.2) | 39(22.8) | 35(21.5) | ||
| Obese | 82(24.6) | 43(25.1) | 39(23.9) | ||
| BMI based on CDC (kg/m2) | Underweight | 18(5.4) | 13(7.6) | 5(3.1) | 0.13 |
| Normal weight | 182(54.5) | 87(50.9) | 95(58.3) | ||
| Overweight | 67(20.1) | 32(18.7) | 35(21.5) | ||
| Obese | 66(20.1) | 39(22.8) | 28(17.2) |
Notes: Data shown as n(%); *Significant. Increased WC: ≥90th percentile, elevated triglycerides: ≥150 mg/dL, low HDL: <40 mg/dL, SBP≥130 mmHg or DBP 85mmHg, and elevated FBS ≥100 mg/dL (1, 2); Cholesterol: ≥200 mg/dL; LDL: ≥200mg/dL.
Abbreviations: WC, waist circumference; BMI, body mass index; FBS, fasting blood sugar; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood pressure; kg, kilogram; m, meter; cm, centimetre; mmHg, millimetre mercury; mg, milligram; dL, deciliter; MetS, metabolic syndrome; CDC, Centers for Disease Control and Prevention; WHO, World Health Organization.
Differences in Metabolic Abnormalities Between Users (Yes) and Non-Users (No)
| Cigarettes | Waterpipe | |||||
|---|---|---|---|---|---|---|
| Yes | No | P-value | Yes | No | P-value | |
| WC (cm) | 78.9(15.0) | 74.4(11.4) | 0.024* | 78.3(13.7) | 74.1(11.3) | 0.008* |
| BMI (kg/m2) | 22.8(6.3) | 21.9(5.0) | 0.15 | 22.8(5.5) | 21.8(5.0) | 0.055 |
| FBS (mg/dL) | 92.7(6.8) | 91.4(7.3) | 0.45 | 92.3(7.3) | 91.4(7.3) | 0.52 |
| Triglycerides (mg/dL) | 99.2(51.2) | 94.0(45.1) | 0.58 | 115.0(66.7) | 90.7(39.7) | 0.01* |
| HDL (mg/dL) | 43.4(9.8) | 49.4(12.4) | 0.015* | 45.0(12.5) | 49.5(12.1) | 0.009* |
| Cholesterol (mg/dL) | 145.9(26.8) | 148.0(27.9) | 0.69 | 148.1(29.5) | 147.8(27.4) | 0.93 |
| LDL (mg/dL) | 85.9(21.1) | 88.0(24.6) | 0.56 | 89.4(26.0) | 87.9(23.9) | 0.97 |
| SBP (mmHg) | 105.8(12.0) | 108.5(14.8) | 0.33 | 106.6(13.0) | 108.6(14.8) | 0.35 |
| DBP (mmHg) | 61.2(12.2) | 66.1(13.0) | 0.136 | 61.8(10.7) | 66.4(13.3) | 0.014* |
| Coffee | Black tea | |||||
| WC (cm) | 74.9(12.1) | 74.9(11.1) | 0.97 | 74.8(12.0) | 74.6(10.7) | 0.70 |
| BMI (kg/m2) | 21.9(5.1) | 22.2(5.2) | 0.82 | 21.7(4.8) | 23.9(6.5) | 0.123 |
| FBS (mg/dL) | 91.3(7.2) | 92.2(7.3) | 0.37 | 91.7(7.4) | 90.1(6.3) | 0.32 |
| Triglycerides (mg/dL) | 94.0(42.5) | 95.9(53.6) | 0.87 | 93.0(47.2) | 91.7(31.3) | 0.63 |
| HDL (mg/dL) | 48.4(12.2) | 50.1(12.5) | 0.32 | 48.8(12.4) | 49.7(10.9) | 0.58 |
| Cholesterol (mg/dL) | 147.6(26.6) | 148.4(30.7) | 0.71 | 147.2(26.9) | 154.5(33.8) | 0.38 |
| LDL (mg/dL) | 88.3(23.0) | 87.7(27.4) | 0.55 | 87.5(23.2) | 93.7(31.2) | 0.36 |
| SBP (mmHg) | 107.9(14.0) | 109.1(16.0) | 0.54 | 107.9(14.3) | 110.0(15.7) | 0.41 |
| DBP (mmHg) | 65.6(12.4) | 65.6(14.8) | 0.92 | 65.2(12.7) | 68.0(15.2) | 0.24 |
| Energy drinks | Chocolate | |||||
| WC (cm)a | 77.1(13.2) | 72.8(10.1) | 0.03* | 74.4(11.8) | 81.4(116.6) | 0.008* |
| BMI (kg/m2) | 22.5(5.5) | 21.5(4.8) | 0.17 | 21.8(5.0) | 24.2(5.8) | 0.13 |
| FBS (mg/dL) | 93.0(7.0) | 90.2(7.3) | 0.003* | 91.6(7.4) | 91.1(6.4) | 0.98 |
| Triglycerides (mg/dL) | 99.1(48.6) | 90.5(42.7) | 0.26 | 94.6(46.6) | 94.7(33.8) | 0.59 |
| HDL (mg/dL) | 48.9(12.9) | 48.8(11.7) | 0.91 | 49.2(12.5) | 43.6(8.4) | 0.04* |
| Cholesterol (mg/dL) | 149.3(28.0) | 146.5(27.6) | 0.55 | 148.1(28.0) | 144.4(24.5) | 0.51 |
| LDL (mg/dL) | 89.4(24.5) | 87.1(24.0) | 0.27 | 87.9(24.5) | 90.6(21.4) | 0.79 |
| SBP (mmHg) | 108.3(14.3) | 108.1(14.8) | 0.95 | 108.2(14.4) | 108.5(17.6) | 0.54 |
| DBP (mmHg) | 65.1(13.9) | 66.0(12.1) | 0.53 | 65.8(12.9) | 63.0(14.6) | 0.92 |
Notes: Data shown in mean (SD); *Significant. Increased WC: ≥90th percentile, Increased FBS: ≥100 mg/dL; increased triglycerides: ≥150 mg/dL, Low HDL: <40 mg/dL, Increased SBP: ≥130 mmHg or DBP ≥85mmHg; Increased Cholesterol: ≥200 mg/dLl; Increased LDL: ≥200 mg/dL.
Abbreviations: WC, waist circumferences; BMI, body mass index; FBS, fasting blood sugar; HDL, high density lipoprotein; LDL, low density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood pressure; kg, kilogram; m, meter; cm, centimetre; mmHg, millimetre mercury; mg, milligram; dL, deciliter.
Univariate Analysis for Metabolic Syndrome and Tested CE/PS
| Have Metabolic Syndrome | Do Not Have Metabolic Syndrome | Odds Ratio | 95% Confidence Interval | P-value | ||
|---|---|---|---|---|---|---|
| Cigarette smoking | Yes | 5(19.2) | 21(80.8) | 4.60 | 1.48–14.32 | 0.008* |
| No | 12(4.9) | 232(95.1) | ||||
| Waterpipe smoking | Yes | 6(14.3) | 36(85.7) | 3.29 | 1.14–9.45 | 0.027* |
| No | 11(4.8) | 217(95.2) | ||||
| Energy drink consumption | Yes | 14(11.2) | 111(88.8) | 5.97 | 1.67–21.29 | 0.002* |
| No | 3(2.1) | 142(97.9) | ||||
| Coffee consumption | Yes | 13(6.5) | 187(93.5) | 1.16 | 0.37–3.70 | 1.00 |
| No | 4(5.6) | 67(94.4) | ||||
| Black tea consumption | Yes | 14(5.9) | 225(94.1) | 0.87 | 0.19–4.03 | 0.70 |
| No | 2(6.7) | 28(93.3) | ||||
| Chocolate consumption | Yes | 13(5.2) | 236(94.8) | 0.20 | 0.06–0.71 | 0.02* |
| No | 4(21.1) | 15(78.9) | ||||
| Gender | Male | 10(7.4) | 125(92.6) | 1.47 | 0.54–3.99 | 0.45 |
| Female | 7(5.1) | 129(94.9) | ||||
| Body mass index | Underweight | 0(0.0) | 14(100.0) | <0.001* | ||
| Normal weight | 0(0.0) | 134(100.0) | ||||
| Overweight | 3(5.2) | 55(94.8) | ||||
| Obese | 14(21.5) | 51(78.5) | ||||
| Low-Density Lipoprotein | High | 1(10.0) | 9(90.0) | 1.70 | 0.20–14.27 | 0.62 |
| Normal | 16(6.1) | 245(93.9) |
Notes: Data shown as n (%); *Significant.
Model 1: Adjusted Binary Logistic Regression for MetS and Tested CE/PS Use
| Metabolic Syndrome (Yes)# | Variable | Reference Category | Odds Ratio | 95% (CI) | P-value |
|---|---|---|---|---|---|
| Cigarettes smoking | Yes | No | 3.07 | 0.56–16.9 | 0.20 |
| Waterpipe smoking | Yes | No | 1.36 | 0.30–6.13 | 0.69 |
| Energy drink consumption | Yes | No | 9.97 | 1.45–68.39 | 0.019* |
| Coffee consumption | Yes | No | 1.22 | 0.27–5.56 | 0.80 |
| Chocolate consumption | Yes | No | 0.14 | 0.02–0.96 | 0.046* |
| Black tea consumption | Yes | No | 7.87 | 0.57–109.1 | 0.12 |
| Gender | Male | Female | 0.79 | 0.16–3.84 | 0.77 |
| Age | 0.80 | 0.40–1.59 | 0.52 | ||
| Body Mass Index | 1.35 | 1.19–1.52 | <0.001* |
Notes: #Reference category is No metabolic syndrome; *Significant.
Abbreviations: CI, confidence interval; MetS, metabolic syndrome; CE/PS, cognitive enhancers/psychostimulants.
Model 2: Adjusted Binary Logistic Regression for Increased Triglycerides and CE/PS Use
| High Triglycerides Plasma Level Yes# | |||||
|---|---|---|---|---|---|
| Variable | Reference | OR | 95% (CI) | P-value | |
| Cigarettes smoking | Yes | No | 0.67 | 0.15–3.10 | 0.611 |
| Waterpipe smoking | Yes | No | 3.45 | 1.30–10.60 | 0.03* |
| Energy drinks consumption | Yes | No | 0.94 | 0.33–2.65 | 0.90 |
| Coffee consumption | Yes | No | 0.43 | 0.15–1.20 | 0.11 |
| Chocolate | Yes | No | 0.59 | 0.13–2.71 | 0.49 |
| Black tea consumption | Yes | No | 2.00 | 0.33–12.90 | 0.45 |
| WC | High | Normal | 4.77 | 1.29–17.68 | 0.02* |
| FBS | High | Normal | 0.99 | 0.93–1.06 | 0.835 |
| Cholesterol | High | Normal | 8.99 | 1.85–43.75 | 0.007* |
| Gender | Male | Female | 1.35 | 0.47–3.85 | 0.57 |
| Age | 0.78 | 0.47–1.29 | 0.33 | ||
| Body mass index (BMI) | 1.05 | 0.95–1.17 | 0.34 | ||
Notes: #Reference category is Normal triglycerides plasma level; *Significant. Increased WC: ≥90th percentile, Increased FBS: ≥100 mg/dL; Increased Cholesterol: ≥200 mg/dL.
Abbreviations: OR, odds ratio; CI, confidence interval; CE/PS, cognitive enhancers/psychostimulants; WC, waist circumferences; FBS, fasting blood sugar.